A two-arm cluster-randomised trial in 31 paediatric practices in Colorado and California compared introducing HPV vaccination at ages 9-10 with the routine 11-12. Median age at series completion was 12.2 years in the earlier-offer arm as compared to 13.3 years in the control arm. Completion by age 13 rose from 45.1% to 61.6%, and tetanus and meningococcal vaccination by age 13 was no lower.
Why it is interesting: Randomised evidence that the age at which the vaccine is offered changes when the series is completed.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.